Who
Tao Fu
President and CEO
Company insider
Files Form 4 as: President and CEO, Attovia Therapeutics; President & COO, Zai Lab; EVP, Cbo, Portola Pharmaceuticals.
In numbers
- Trades disclosed
- 92
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $13.3M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 15 Jun 2015
- Last trade
- 4 Aug 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 8 Oct 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —538,300 at $0.00 | filing |
| 28 Oct 2021filed 29 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $216K2,065 at $104.49 | filing |
| 28 Oct 2021filed 29 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $834K7,935 at $105.13 | filing |
| 14 Oct 2021filed 14 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $343K3,360 at $102.02 | filing |
| 14 Oct 2021filed 14 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $539K5,240 at $102.90 | filing |
| 14 Oct 2021filed 14 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $145K1,400 at $103.44 | filing |
| 30 Sep 2021filed 1 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $286K2,714 at $105.55 | filing |
| 30 Sep 2021filed 1 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $493K4,619 at $106.73 | filing |
| 30 Sep 2021filed 1 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $261K2,417 at $107.85 | filing |
| 30 Sep 2021filed 1 Oct 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $27K250 at $108.85 | filing |
| 24 Sep 2021filed 27 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code F | $2.4M19,832 at $119.86 | filing |
| 15 Sep 2021filed 27 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $13K100 at $134.09 | filing |
| 15 Sep 2021filed 16 Sep 2021 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2021filed 16 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code M | $189K10,000 at $18.92 | filing |
| 15 Sep 2021filed 16 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $247K1,978 at $124.98 | filing |
| 15 Sep 2021filed 16 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $390K3,100 at $125.96 | filing |
| 15 Sep 2021filed 16 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $198K1,541 at $128.33 | filing |
| 15 Sep 2021filed 16 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $130K1,007 at $129.29 | filing |
| 15 Sep 2021filed 16 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $75K574 at $130.64 | filing |
| 15 Sep 2021filed 16 Sep 2021 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $172K1,300 at $132.25 | filing |
News
No headline names them, or the companies they trade most, lately.